Search

Your search keyword '"Bilguvar, K"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Bilguvar, K" Remove constraint Author: "Bilguvar, K"
190 results on '"Bilguvar, K"'

Search Results

1. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

2. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

3. Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome

4. X-linked recessive TLR7 deficiency in similar to 1% of men under 60 years old with life-threatening COVID-19

5. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

6. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

7. Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia

8. ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes

10. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss

11. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

12. The distinct genetic pattern of ALS in Turkey: OS2207

13. Bi-allelic GAD1 variants cause a neonatal onset syndromic developmental and epileptic encephalopathy

14. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

15. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

16. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

17. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

18. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

19. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

24. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias

26. De novo mutations in congenital heart disease with neurodevelopmental and other birth defects

27. A new patient with Andermann syndrome: an underdiagnosed clinical genetics entity?

29. Response to letter by Stahl and Felbor [16]

30. Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3

32. Identification of a novel missense mutation in RAD51 in a large family with congenital mirror movements

33. Genome-wide association study of intracranial aneurysm identifies three new risk loci

34. PATHOLOGY

35. OMICS AND PROGNSTIC MARKERS

39. The distinct genetic pattern of ALS in Turkey

40. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

41. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

42. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

43. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss

45. The distinct genetic pattern of ALS in Turkey and novel mutations

46. Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk

47. Molecular genetic analysis of two large kindreds with intracranial aneurysms demonstrates linkage to 11q24-25 and 14q23-31

48. Rapid genome sequencing for critically ill infants: an inaugural pilot study from Turkey.

49. Reply to Pisan et al.: Pathogenicity of inherited TRAF7 mutations in congenital heart disease.

50. TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions.

Catalog

Books, media, physical & digital resources